Exeter Financial
CVS icon

Exeter Financial’s CVS Health CVS Stock Holding History

Exeter Financial’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.78M Sell
32,415
-2,568
-7% -$251K 1.05% 35
2026
Q2 		$3.62M Sell
34,983
-2,597
-7% -$232K 1.38% 27
2026
Q1 		$2.7M Sell
37,580
-35
-0.1% -$2.7K 1.1% 35
2025
Q4 		$2.99M Sell
37,615
-1,165
-3% -$91.8K 1.27% 31
2025
Q3 		$2.92M Sell
38,780
-411
-1% -$28.2K 1.26% 30
2025
Q2 		$2.7M Sell
39,191
-2,883
-7% -$189K 1.2% 32
2025
Q1 		$2.85M Buy
42,074
+2,035
+5% +$122K 1.28% 28
2024
Q4 		$1.8M Sell
40,039
-5,525
-12% -$310K 0.82% 43
2024
Q3 		$2.87M Buy
45,564
+1,040
+2% +$60.7K 1.27% 31
2024
Q2 		$2.63M Buy
44,524
+11,600
+35% +$726K 1.25% 31
2024
Q1 		$2.43M Buy
32,924
+225
+0.7% +$17.2K 1.12% 36
2023
Q4 		$2.63M Buy
32,699
+1,000
+3% +$71.2K 1.27% 29
2023
Q3 		$2.21M Sell
31,699
-950
-3% -$67.3K 1.17% 37
2023
Q2 		$2.33M Buy
32,649
+2,525
+8% +$180K 1.2% 35
2023
Q1 		$2.29M Buy
30,124
+2,297
+8% +$193K 1.15% 35
2022
Q4 		$2.59M Buy
27,827
+350
+1% +$33.8K 1.35% 25
2022
Q3 		$2.62M Buy
27,477
+277
+1% +$27.4K 1.52% 23
2022
Q2 		$2.52M Buy
27,200
+450
+2% +$43.9K 1.41% 26
2022
Q1 		$2.71M Sell
26,750
-125
-0.5% -$13.1K 1.47% 25
2021
Q4 		$2.82M Sell
26,875
-575
-2% -$53.1K 1.55% 26
2021
Q3 		$2.33M Buy
27,450
+100
+0.4% +$8.38K 1.39% 27
2021
Q2 		$2.25M Hold
27,350
– – 1.31% 27
2021
Q1 		$2.06M Buy
27,350
+600
+2% +$43.7K 1.3% 30
2020
Q4 		$1.83M Hold
26,750
– – 1.27% 28
2020
Q3 		$1.56M Buy
26,750
+300
+1% +$18.7K 1.22% 32
2020
Q2 		$1.72M Sell
26,450
-1,250
-5% -$78.7K 1.43% 26
2020
Q1 		$1.64M Buy
27,700
+7,050
+34% +$471K 1.54% 25
2019
Q4 		$1.53M Buy
20,650
+1,300
+7% +$91.3K 1.19% 35
2019
Q3 		$1.22M Buy
+19,350
New +$1.15M 0.97% 42

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Exeter Financial's CVS Position: Q3 2026 in Review

Exeter Financial reduced its CVS Health (CVS) stake by 7.3% in Q3 2026, selling an estimated $251K and leaving 32,415 shares worth $2.78M. The position accounts for 1.05% of the portfolio, ranked #35.

Exeter Financial first reported a position in CVS in Q3 2019 and has held it in 29 quarters since. The position peaked at $3.62M in Q2 2026. 808 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Exeter Financial held 32,415 shares of CVS Health worth $2.78M as of Q3 2026.
  • Exeter Financial sold 2,568 CVS Health shares in Q3 2026, an estimated $251K.
  • CVS Health made up 1.05% of Exeter Financial's portfolio in Q3 2026, its #35 holding.
  • Exeter Financial first reported a position in CVS Health in Q3 2019 and has held it in 29 quarters since.
  • Exeter Financial's CVS Health position peaked at $3.62M in Q2 2026.
  • 808 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Exeter Financial's 13F filing for Q3 2026, filed 8 Oct 2026.